TY - JOUR
T1 - Burden of Stroke in Europe
T2 - An Analysis of the Global Burden of Disease Study Findings From 2010 to 2019
AU - Prendes, Carlota F.
AU - Rantner, Barbara
AU - Hamwi, Tarek
AU - Stana, Jan
AU - Feigin, Valery L.
AU - Stavroulakis, Konstantinos
AU - Tsilimparis, Nikolaos
AU - GBD Collaborators Study Group
AU - Prendes, Carlota Fernandez
AU - Rantner, Barbara
AU - Hamwi, Tarek
AU - Stana, Jan
AU - Feigin, Prof Valery L
AU - Stavroulakis, Konstantinos
AU - Tsilimparis, Nikolaos
AU - Aboyans, Prof Victor
AU - Akinyemi, Rufus Olusola
AU - Salman, Prof Rustam Al-Shahi
AU - Artamonov, Anton A
AU - Aujayeb, Avinash
AU - Baldereschi, Marzia
AU - Basu, Sanjay
AU - Béjot, Prof Yannick
AU - Belo, Luis
AU - Bennett, Derrick A
AU - Bhagavathula, Akshaya Srikanth
AU - Bikbov, Boris
AU - Brenner, Prof Hermann
AU - Santos, Florentino Luciano Caetano dos
AU - Carrero, Prof Juan J
AU - Carvalho, Prof Felix
AU - Catapano, Prof Alberico L
AU - Charalampous, Periklis
AU - Christensen, Prof Hanne
AU - Chung, Sheng-Chia
AU - Cortesi, Paolo Angelo
AU - Costa, Vera Marisa
AU - Cyganska, Malgorzata
AU - D’Amico, Emanuele
AU - Davletov, Kairat
AU - Dokova, Klara Georgieva
AU - Douiri, Abdel
AU - Fagbamigbe, Adeniyi Francis
AU - Fischer, Florian
AU - Ghith, Nermin
AU - Giampaoli, Simona
AU - Gill, Prof Paramjit Singh
AU - Gnedovskaya, Elena V
AU - Molokhia, Mariam
AU - Wafa, Hatem A
AU - Wang, Yanzhong
N1 - Funding Information:
The GBD is funded by the Bill & Melinda Gates Foundation.
Publisher Copyright:
© 2024 Lippincott Williams and Wilkins. All rights reserved.
PY - 2024/2/1
Y1 - 2024/2/1
N2 - BACKGROUND:While most European Regions perform well in global comparisons, large discrepancies within stroke epidemiological parameters exist across Europe. The objective of this analysis was to evaluate the stroke burden across European regions and countries in 2019 and its difference to 2010.METHODS:The GBD 2019 analytical tools were used to evaluate regional and country-specific estimates of incidence, prevalence, deaths, and disability-adjusted life years of stroke for the European Region as defined by the World Health Organization, with its 53 member countries (EU-53) and for European Union as defined in 2019, with its 28 member countries (EU-28), between 2010 and 2019. Results were analyzed at a regional, subregional, and country level.RESULTS:In EU-53, the absolute number of incident and prevalent strokes increased by 2% (uncertainty interval [UI], 0%–4%), from 1 767 280 to 1 802 559 new cases, and by 4% (UI, 3%–5%) between 2010 and 2019, respectively. In EU-28, the absolute number of prevalent strokes and stroke-related deaths increased by 4% (UI, 2%–5%) and by 6% (UI, 1%–10%), respectively. All-stroke age-standardized mortality rates, however, decreased by 18% (UI, −22% to −14%), from 82 to 67 per 100 000 people in the EU-53, and by 15% (UI, −18% to −11%), from 49.3 to 42.0 per 100 000 people in EU-28. Despite most countries presenting reductions in age-adjusted incidence, prevalence, mortality, and disability-adjusted life year rates, these rates remained 1.4×, 1.2×, 1.6×, and 1.7× higher in EU-53 in comparison to the EU-28.CONCLUSIONS:EU-53 showed a 2% increase in incident strokes, while they remained stable in EU-28. Age-standardized rates were consistently lower for all-stroke burden parameters in EU-28 in comparison to EU-53, and huge discrepancies in incidence, prevalence, mortality, and disability-adjusted life-year rates were observed between individual countries.
AB - BACKGROUND:While most European Regions perform well in global comparisons, large discrepancies within stroke epidemiological parameters exist across Europe. The objective of this analysis was to evaluate the stroke burden across European regions and countries in 2019 and its difference to 2010.METHODS:The GBD 2019 analytical tools were used to evaluate regional and country-specific estimates of incidence, prevalence, deaths, and disability-adjusted life years of stroke for the European Region as defined by the World Health Organization, with its 53 member countries (EU-53) and for European Union as defined in 2019, with its 28 member countries (EU-28), between 2010 and 2019. Results were analyzed at a regional, subregional, and country level.RESULTS:In EU-53, the absolute number of incident and prevalent strokes increased by 2% (uncertainty interval [UI], 0%–4%), from 1 767 280 to 1 802 559 new cases, and by 4% (UI, 3%–5%) between 2010 and 2019, respectively. In EU-28, the absolute number of prevalent strokes and stroke-related deaths increased by 4% (UI, 2%–5%) and by 6% (UI, 1%–10%), respectively. All-stroke age-standardized mortality rates, however, decreased by 18% (UI, −22% to −14%), from 82 to 67 per 100 000 people in the EU-53, and by 15% (UI, −18% to −11%), from 49.3 to 42.0 per 100 000 people in EU-28. Despite most countries presenting reductions in age-adjusted incidence, prevalence, mortality, and disability-adjusted life year rates, these rates remained 1.4×, 1.2×, 1.6×, and 1.7× higher in EU-53 in comparison to the EU-28.CONCLUSIONS:EU-53 showed a 2% increase in incident strokes, while they remained stable in EU-28. Age-standardized rates were consistently lower for all-stroke burden parameters in EU-28 in comparison to EU-53, and huge discrepancies in incidence, prevalence, mortality, and disability-adjusted life-year rates were observed between individual countries.
UR - http://www.scopus.com/inward/record.url?scp=85183216007&partnerID=8YFLogxK
U2 - 10.1161/STROKEAHA.122.042022
DO - 10.1161/STROKEAHA.122.042022
M3 - Article
SN - 0039-2499
VL - 55
SP - 432
EP - 442
JO - Stroke
JF - Stroke
IS - 2
ER -